Navigation Links
The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement
Date:7/22/2014

Piscataway, NJ (PR Web) July 21, 2014 (PRWEB) July 23, 2014

The New Jersey Center for Biomaterials, at Rutgers University.

The goal of the Symposium is to exchange information and ideas across the full spectrum of scientists working in the biomaterials field, by focusing on selected research and development topics that represent the most promising directions for ultimate medical application. Activities have been programmed to:

  •     Provide faculty and government scientists with opportunities for high-level scientific interactions with leading investigators in similar and complementary disciplines; and with commercially oriented biomaterials users
  •     Provide students and postdoctoral associates with opportunities both to learn about the most advanced biomaterials-related research, and to present their own research in a professional forum; and to interact with industrial scientists in furtherance of exploring future career options
  •     Provide industrial scientists with access to leading-edge academic biomaterials researchers, and the opportunity to contribute to defining university-based research directions
  •     Provide clinicians with current information on biomaterials research and product development, and the opportunity to shape R&D programs through clinical input

Registration for the 12th NJ Symposium on Biomaterials Science is available at http://www.njbiomaterials.org/biomaterials-symposia.htm

The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.

The Society For Biomaterials is a multidisciplinary society of academic, healthcare, governmental and business professionals in the US, dedicated to promoting advances in all aspects of biomaterial science, education and professional standards.

Media Contact:

Louli Kourkounakis
(732) 445 0488 ext. 40001
symposium(at)dls(dot)rutgers(dot)edu

Read the full story at http://www.prweb.com/releases/2014/07/prweb12033279.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
2. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
3. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
4. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
5. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
6. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
7. Amarantus BioSciences Featured in BioWorld Today, Brewer Sports Symposium and Opportunist Magazine
8. Tanke BioSciences To Host Leading Symposium On Food Safety, June 24-25
9. Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
10. Van Andel Institute Research Symposium Showcases Latest Developments In Parkinsons Research
11. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... HILL, N.C. , Feb. 5, 2016  In ... key role for a host of launch activities including ... importance of this launch activity is especially high in ... specialists. Best Practices and the Role of ... will help companies focused on oncology therapies find better ...
(Date:2/4/2016)... Massachusetts , February 4, 2016 - New FDA ... - New FDA action date of July 22, ... of July 22, 2016   - ... U.S. in the past decade indicated for the treatment of signs and symptoms ... Lifitegrast has the potential to be the only product approved in the U.S. ...
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... SAN JOSE, Calif. , Jan. 11, 2016 /PRNewswire/ ... developer of human interface solutions, today announced that its ... display driver integration (TDDI) products won two separate categories ... including Best Mobile Innovator and Best Technology Breakthrough. The ... overall system cost, a simplified supply chain, thinner devices, ...
(Date:1/7/2016)... Various factors have contributed to the ... biologics and biosimilars. Some of these factors include ... demand for cost-effective alternatives, growing burden of chronic ... versions of their corresponding patented biologic drugs, and ... and efficacy. The global biosimilars market is estimated ...
Breaking Biology News(10 mins):